2'-fluoroncucleosides

A technology for replacing nucleosides and bases, which is applied in the field of 2'-fluoro nucleosides and its preparation, and can solve problems such as cleavage of glucosyl bonds and difficulties in fluorine groups.

Inactive Publication Date: 2007-12-19
EMORY UNIVERSITY +9
View PDF33 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At least with respect to 2′-ribofuranosyl nucleosides, this may be due to the previous perception that placing the fluorine group in the 2′-ribofuranosyl configuration was difficult
For L-2'-fluoro-2',3'-unsaturated purine nucleosides, it may be due to the instability of purine nucleosides in acidic media, resulting in the cleavage of the glucosyl bond

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2'-fluoroncucleosides
  • 2'-fluoroncucleosides
  • 2'-fluoroncucleosides

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0073] The invention disclosed herein relates to a compound, method and composition for the treatment of HIV, hepatitis (B or C) or abnormal cell proliferation in a human or other animal host comprising the use of An effective amount of 2'-fluoro-nucleoside, a pharmaceutically acceptable derivative (including compounds that have been alkylated or acylated at the 5'-position or at a purine or pyrimidine), or a pharmaceutically acceptable salt thereof. Compounds of the invention possess antiviral (ie anti-HIV-1, anti-HIV-2 or anti-hepatitis (B or C)) activity, or antiproliferative activity, or are metabolized to compounds having these activities.

[0074] In summary, the present invention includes the following features:

[0075] (a) β-L and β-D-2'-fluoronucleosides, as described herein, and pharmaceutically acceptable derivatives and pharmaceutically acceptable salts thereof,

[0076] (b) β-L and β-D-2'-fluoronucleosides, as described herein, and pharmaceutically acceptable de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

2'-fluoronucleoside compounds are disclosed for use in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cell proliferation including tumors and cancers. These compounds have the general formula (I), (II), (III), (IV) or pharmaceutically acceptable salts thereof, wherein the base is a purine or pyrimidine base; R 1 is OH, H, OR 3 , N 3 , CN, halogen including F, or CF 3 , lower alkyl, amino, lower alkylamino, two lower alkylamino, or alkoxy; R 2 is H, phosphate, including monophosphate, diphosphate, triphosphate, or a stable phosphate prodrug; acyl, or other pharmaceutically acceptable leaving group that provides R when used in vivo 2 Compounds that are H or phosphate; sulfonates include alkyl or aralkylsulfonyl, including methylsulfonyl, benzyl, wherein phenyl is optionally substituted by one or more of the substituents described above in the definition of aryl substitution, lipid, amino acid, peptide or cholesterol; and R 3 is an acyl, alkyl, phosphate or other pharmaceutically acceptable leaving group, ie, a group that cleaves to the parent compound when used in vivo.

Description

[0001] This application is a divisional application of the invention patent application PCT / US99 / 04051 filed on February 25, 1999, entitled "2'-Fluoronucleoside", and the Chinese patent application number of the original application is 99805472.0. [0002] The invention described herein was made with government support under Grant No. AI32351 awarded by the National Department of Health. The United States Government has asserted rights in this invention. technical field [0003] The invention belongs to the field of medicinal chemistry, and specifically includes 2'-fluoronucleosides, a preparation method and application thereof. Background technique [0004] Synthetic nucleosides such as 5-iodo-2'-deoxyuridine and 5-fluoro-2'-deoxyuridine have been used for some years in the treatment of cancer and herpes viruses. Since the 1980s, synthetic nucleosides have also been beneficial in the treatment of HIV, hepatitis and Epstein-Barr virus. [0005] In 1981, Acquired Immunodefi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07H19/06C07H19/10C07D405/04C07D473/00C07F9/547C07H19/16C07H19/20C07H19/207A61K31/70A61P1/16A61P31/12A61P31/18A61P35/00
Inventor 雷蒙德F·辛纳兹丹尼斯C·利奥塔C·K·朱J·杰弗里·麦卡蒂施俊生Y·蔡K·李J·H·洪
Owner EMORY UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products